As the global economy recovers in 2021 and the supply of the industrial chain improves, the Pharmacogenomics Services market will undergo major changes. According to the latest research, the market size of the Pharmacogenomics Services industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.

The global Pharmacogenomics Services industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.

The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Pharmacogenomics Services market during the next few years. The global Pharmacogenomics Services market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.

Highlights-Regions

The Pharmacogenomics Services market can be split based on product types, major applications, and important regions as follows:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Highlights-Players
Major Players in Pharmacogenomics Services market are:
Abbott Laboratories
Admera Health, LLC
Mesa Laboratories, Inc.
Dynamic DNA Laboratories
F. Hoffmann-La Roche Ltd.
GeneOmbio Technologies Pvt Ltd.
Exact Sciences Corporation
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
OmeCare
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
Precipio
23andMe, Inc.
OneOme, LLC
DiaCarta, Inc.
OPKO Health

Highlights-Types
Most important types of Pharmacogenomics Services products covered in this report are:
Genotyping
SNP Identification
Pharmacogenetic Testing
Others

Application listHighlights-Application
Most widely Application of Pharmacogenomics Services market covered in this report are:
Oncology
Infectious Diseases
Psychiatry
Cardiovascular
Others